Tumor-suppressing effect of bartogenic acid in ovarian (SKOV-3) xenograft mouse model.
Sign Up to like & getrecommendations! Published in 2021 at "Naunyn-Schmiedeberg's archives of pharmacology"
DOI: 10.1007/s00210-021-02088-0
Abstract: Bartogenic acid (BA), a natural pentacyclic triterpenoid, proved to have chemomodulatory, anticancer, antidiabetic, anti-arthritic, and anti-inflammatory activity. Based on structure-activity relationship (SAR) approaches, BA has close structural resemblance to oleanolic acid and ursolic acid. These… read more here.
Keywords: effect; bartogenic acid; combination paclitaxel; skov ... See more keywords
Phase Ib Study of the Histone Deacetylase 6 Inhibitor Citarinostat in Combination With Paclitaxel in Patients With Advanced Solid Tumors
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2021.786120
Abstract: Background Citarinostat (CC-96241; previously ACY-241), an oral inhibitor of histone deacetylases (HDACs) with selectivity for HDAC6, has demonstrated synergistic anticancer activity with paclitaxel in multiple solid tumor models. Combination therapy using citarinostat with paclitaxel was… read more here.
Keywords: patients advanced; combination paclitaxel; advanced solid; solid tumors ... See more keywords
Preclinical studies for the combination of paclitaxel and curcumin in cancer therapy (Review).
Sign Up to like & getrecommendations! Published in 2017 at "Oncology reports"
DOI: 10.3892/or.2017.5593
Abstract: Cancer is one of the most common causes of death and remains the first in China and the second in the US. The common treatments for cancer include surgery, radiation, chemotherapy, targeted therapy and immunotherapy,… read more here.
Keywords: therapy; cancer; combination paclitaxel; cancer therapy ... See more keywords